Exploratory clinical study of silkworm cordyceps for targeting dementia patients

A clinical study on the efficacy and safety of silkworm Cordyceps for cognitive function in patients with dementia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031200291

Enrollment

Registered

2021-01-13

Start date

2021-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Dementia

Interventions

Silkworm Cordyceps

Dementia, Silkworm Cordyceps

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dementia over the preceding 6 months as the following criteria 1.Persons with an MMSE result of 21 or less 2.Those who are not in the habit of taking foods containing Cordyceps 3.Those who do not regularly use supplements and health foods 4.Those who have no history of treatment for malignant tumor, heart failure, myocardial infarction 5.Those who are not allergic to foods and medicines containing Cordyceps 6.Those who fully understand the content of clinical trials and have written consent

Exclusion criteria

Exclusion criteria: 1.Pregnant or breast-feeding woman or person who is willing to become pregnant during the test period 2.Those who are participating in other clinical trials and those who have participated in other clinical trials within 3 months 3.Those who cannot follow the instructions of the physicians and medical staff 4.A person who has been judged by a physicians to have any problems

Design outcomes

Primary

Measure	Time frame
Cognitive function evaluation by eye tracking	—

Contacts

Public ContactSaito Daisuke

DKS Co. Ltd.

d.saito@dks-web.co.jp+81-75-326-7572

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026